What is the recommended treatment for shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Shingles Treatment Recommendations

For shingles (herpes zoster), valacyclovir 1 gram three times daily for 7 days is the recommended first-line treatment, which should be initiated at the earliest sign or symptom of herpes zoster and within 48 hours of rash onset for maximum effectiveness. 1

Antiviral Medication Options

First-line Treatment:

  • Valacyclovir: 1 gram orally 3 times daily for 7 days 1
    • Most effective when started within 48 hours of rash onset
    • Provides faster resolution of zoster-associated pain compared to acyclovir 2

Alternative Antiviral Options:

  • Famciclovir: 500 mg orally 3 times daily for 7 days 3, 4

    • Similar efficacy to valacyclovir in speeding resolution of acute rash and shortening postherpetic neuralgia duration 2
  • Acyclovir: 800 mg orally 5 times daily for 7 days 5, 6

    • Less convenient dosing schedule
    • Lower bioavailability compared to valacyclovir 2

Treatment Considerations

Timing of Treatment:

  • Initiate treatment at the earliest sign or symptom of herpes zoster 1, 3
  • Ideally within 72 hours of rash onset 5, 7
  • Some benefit may still be obtained when starting treatment after 72 hours in certain cases 2

Special Populations:

  • Patients with severe cases: Consider intravenous acyclovir 5-10 mg/kg body weight every 8 hours for 5-7 days 8

  • Renal Impairment: Dose adjustments required 8, 1

    Creatinine Clearance Valacyclovir Dosing Adjustment
    ≥50 mL/min No adjustment needed
    10-29 mL/min 1 gram every 24 hours
    <10 mL/min 500 mg every 24 hours

Ocular Involvement:

  • Patients with herpes zoster ophthalmicus should be referred to an ophthalmologist 5, 7
  • Antiviral therapy remains important for these patients 2

Management of Complications

Postherpetic Neuralgia:

Postherpetic neuralgia (PHN) occurs in approximately 20% of patients with herpes zoster 7. Treatment options include:

  • First-line options:

    • Gabapentin or pregabalin 7
    • Tricyclic antidepressants (e.g., amitriptyline) 5, 7
  • Topical treatments:

    • Lidocaine patches 5, 7
    • Capsaicin 5, 7
  • For severe pain:

    • Opioid analgesics may be necessary 5
    • Nerve blocks in selected patients 5

Patient Education and Monitoring

  • Advise patients to keep the rash clean and dry to prevent secondary bacterial infection
  • Explain that the rash typically progresses to clear vesicles that become cloudy and crust over in 7-10 days 7
  • Inform patients that pain may persist after the rash resolves (postherpetic neuralgia)
  • Follow up until complete resolution of lesions 8
  • Monitor for complications such as secondary bacterial infection 8

Prevention

  • Zoster vaccine is recommended for adults 60 years and older to decrease the incidence of herpes zoster 7
  • The vaccine is approved for adults 50 years and older but specifically recommended by CDC for those 60+ 7

Common Pitfalls to Avoid

  • Delayed treatment: Starting antivirals after 72 hours significantly reduces their effectiveness
  • Inadequate pain management: Underestimating the severity of acute and chronic pain
  • Missing ocular involvement: Failing to recognize and refer cases with eye involvement
  • Insufficient duration: Using shorter courses of antivirals than recommended
  • Overlooking renal function: Not adjusting doses in patients with renal impairment

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.